Skip to content

Savara SVRA Operating Cash Flow

Operating Cash Flow at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$9.87M+198%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$6.14M+175%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$35.28M-27.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$73.28M+70.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$58.38M+66.8%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$7.41M+254%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+236%
Enterprise value$1.19B+224%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's operating cash flow?
Savara (SVRA) reported operating cash flow of -$33.05M in Q1 2026.
How has Savara's operating cash flow changed year-over-year?
Savara's operating cash flow decreased by 21.5% year-over-year, from -$27.19M to -$33.05M.
What is the long-term trend for Savara's operating cash flow?
Over 4 years (2021 to 2025), Savara's operating cash flow has grown at a 26.0% compound annual growth rate (CAGR), from -$40.08M to -$101.04M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.